Latest News and Press Releases

Stryve Foods, Inc. (OTC: SNAX) Announces Exploration of Strategic Alternatives

Revenus records : Revenus nets de 26,6 millions de dollars au deuxième trimestre de 2025, soit une augmentation de 35 % par rapport aux 19,7 millions de dollars du deuxième trimestre de 2024, grâce à...

Cannara Biotech reports record Q2 2025 results with 35% revenue growth, expanded market share, and strong profitability across Canadian cannabis markets.

Stryve Foods, Inc. (OTC: SNAX) Announces Prelim FY'24 Financial Results and Filing of Form 12b-25

Cannara Biotech fera une présentation à la conférence canadienne sur le cannabis Ventum le 12 mars 2025, mettant en valeur son succès financier...

Cannara Biotech will present at the Ventum Canadian Cannabis Conference on March 12th, 2025, showcasing its financial success, market growth, and cost adv.

MONTRÉAL, 24 févr. 2025 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (« Cannara », « la Société », « nous » ou « notre ») (TSXV : LOVE) (OTCQB : LOVFF) (FRA : 8CB0), producteur verticalement...

Cannara Biotech extends BMO credit to 2027, Olymbec debenture to 2028, partners with Integral for market-making, Impaq for IR

Stryve Foods, Inc. (OTC: SNAX) Announces Distribution Wins with Kroger, Key Foods, and Other Leading Retailers

Cannara Biotech reported record Q1 2025 revenues of $25.1M, a 29% YoY increase, achieving 4.1% Canadian market share, 15th positive EBITDA quarter